July 23, 2025 • By Kelly Gebo

The article discusses how companies in regulated industries, such as health tech and fin tech, can adopt an agile approach to software development without compromising compliance. It highlights the benefits of agile development, including faster time to market, higher user satisfaction, and reduced risk. The article provides tips for applying agile thinking in the earliest stages of product development, such as prioritizing features based on real user feedback and planning a tech stack for future growth. It also emphasizes the importance of continuous documentation, ruthless prioritization, and iterative integration to minimize risk and stay agile. The article concludes by offering help and guidance from the thoughtbot team, which has over 20 years of experience in delivering exceptional products through collaborative design and development.

July 21, 2025 • By Medicines and Healthcare products Regulatory Agency

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has announced new steps to improve patient access to the latest medical technologies. The proposals aim to reduce regulatory duplication, improve traceability, and align with international best practice. Key changes include: * Introducing international reliance routes to allow swifter access to medical devices from trusted regulators in Australia, Canada, and the US * Consulting on the indefinite recognition of CE-marked medical devices * Removing physical UKCA marking requirements once Unique Device Identification (UDI) is in place * Streamlining the regulatory process for low-risk devices and introducing a more risk-proportionate approach for certain in vitro diagnostic devices These changes aim to support the growth of the med tech industry, reduce barriers to market entry, and deliver transformative technologies to patients faster. The MHRA's announcement has been welcomed by industry representatives, who see it as a significant step towards a more agile and internationally aligned regulatory system.

July 21, 2025 • By PTI

Venture capital investments in India reached $3.5 billion across 355 deals in Q2 2025, up from $2.8 billion in Q1. Fintech, healthtech, and logistics drew strong investor interest. A $218 million seed round by PB Healthcare was India's largest VC investment in Q2. Globally, VC investment slipped to $101.05 billion in Q2 from $128.4 billion in Q1. Despite this, Q2 remained a relatively strong quarter, with a focus on large-scale opportunities in AI and defencetech. VC investors are expected to remain cautious in Q3 due to ongoing uncertainties. AI is likely to remain a key sector for VC investment globally.

July 21, 2025 • By PTI

Venture capital investments in India increased to $3.5 billion across 355 deals in Q2 2025, up from $2.8 billion in the previous quarter. Fintech, healthtech, and logistics drew significant investor interest, with PB Healthcare's $218 million seed round being the largest VC deal in India. Globally, VC investments decreased to $101.05 billion.

July 21, 2025 • By PTI

Here is a concise summary of the news article: Venture capital investments in India reached $3.5 billion across 355 deals in Q2 2025, up from $2.8 billion in Q1, despite global uncertainty. Fintech, healthtech, and logistics led the activity, with PB Healthcare's $218 million seed round being the largest deal. According to KPMG, India's venture capital landscape demonstrated resilience, with key sectors drawing strong investor interest. Globally, VC investment slipped to $101.05 billion in Q2 2025, but AI is expected to remain a hot sector for investment.

July 19, 2025 • By Martha McHardy

A LinkedIn report has identified 25 US metro areas with strong job growth, economic momentum, and quality of life, attracting new talent. These areas include Grand Rapids, Michigan; Boise, Idaho; Harrisburg, Pennsylvania; and Albany, New York, among others. The report highlights a shift in the geography of opportunity, with economic growth surging in smaller metros with vibrant downtowns and targeted infrastructure investments. Cities like Nashville, Tennessee, and Austin, Texas, are also experiencing growth, with average incomes ranging from $54,210 to $89,095 and home prices varying from $385,955 to $1,087,305. These areas are expected to see continued population growth, housing demand, and competition for talent as companies expand outside of traditional markets.

July 18, 2025 • By ETtech

The provided text is not a news article, but rather a promotional snippet from The Economic Times, directing readers to their website and app for Budget 2024 news and other updates.

July 18, 2025 • By Digital News Asia

Foodpanda Malaysia and Heydoc Health have launched FutureK, a pilot program providing affordable, digital-first outpatient healthcare services to foodpanda delivery partners and their families. The program includes access to digital health education modules, preventive care, chronic condition management, and mental wellbeing support. Built on Heydoc Health's digital infrastructure, FutureK leverages AI, blockchain, and smart medication management tools to offer efficient and cost-effective care. A three-month pilot will collect data and rider input to strengthen the offering before a national rollout. The program aims to address the critical gap in affordable healthcare coverage for gig workers in Malaysia, offering a fixed-fee model with predictable costs and streamlined support.

July 17, 2025 • By Sindhya Valloppillil, Contributor, Sindhya Valloppillil, Contributor https://www.forbes.com/sites/sindhyavalloppillil/

Here is a concise summary of the news article: The pharmaceutical industry is transitioning from exploring AI to executing it, with 85% of surveyed leaders calling AI an "immediate priority." A report by Define Ventures highlights the opportunities and bottlenecks in AI adoption, focusing on clinical R&D, digital biomarkers, and AI-powered infrastructure. While large pharmaceutical companies are investing in AI, startups are innovating and scaling faster, using AI to reshape drug development, personalization, and delivery. The global AI in drug discovery market is projected to reach $11 billion by 2030, and companies like Amazon are constructing parallel infrastructures to treat fulfillment, primary care, and patient data as a single product. Startups like BlueChew, Musely, and Dutch are leading the wave, building direct-to-consumer, vertically integrated platforms that combine telehealth, asynchronous care, and pharmacy fulfillment at scale. The next 12-24 months will shape how AI is embedded in pharma, and the companies winning will be those that own the full experience and design systems that pharma will depend on.

July 17, 2025 • By BL Mumbai Bureau

The Avendus Wealth-Hurun India Uth Series 2025 has released its inaugural list of 79 standout entrepreneurs under 30. The list includes Zepto founders Kaivalya Vohra and Aadit Palicha, AVR Shree Smaran, and Arjun Deshpande, among others. These young entrepreneurs lead ventures with valuations above $25 million and have created over 64,000 jobs, raising over $5 billion in equity. The average age of those featured is 28, with BITS Pilani emerging as the top educational institution. India has 79 young entrepreneurs under 30, behind China and the UK, but leads in job creation with an average of 870 jobs per venture.

July 17, 2025 • By Our Bureau

The Avendus Wealth-Hurun India Uth Series 2025 has released its inaugural list of 79 standout entrepreneurs under 30. Zepto founders Kaivalya Vohra and Aadit Palicha top the list, with their company having raised $1.95 billion in equity funding. Other notable entrepreneurs include Arjun Deshpande of Generic Aadhaar and Devika Gholap of OptraSCAN. The list highlights the achievements of young entrepreneurs in India, with an average age of 28 and an average of 870 jobs created per venture. India ranks third in the number of young entrepreneurs under 30, behind China and the UK. The list also notes regional differences in gender representation, with China having the most women featured at 27, followed by the UK at 21 and India at 6.

July 16, 2025 • By Ben Lovejoy

The US International Trade Commission (ITC) has upheld a complaint by Samsung that China's BOE stole trade secrets related to OLED screens. As a result, the ITC has banned the import of products containing these screens. However, Apple has confirmed that the ban does not affect any of its products, including iPhones, as the ban applies to specific OLED screen types not used in iPhones. Apple sources iPhone displays from Samsung, LG, and BOE, but the company stated that the order has no impact on any Apple products.

July 16, 2025 • By Allie Garfinkle

H2Ok Innovations has raised $12 million in Series A funding to improve manufacturing precision for clients like Coca-Cola and Unilever. The company, founded by Annie and David Lu, aims to optimize manufacturing processes by providing real-time data and analytics. This investment is part of a larger trend of startups raising funds to develop innovative technologies, including AI, cybersecurity, and data analytics. Other notable investments include Thinking Machines Lab's $2 billion mega-seed round and Unify's $40 million Series B funding.

July 16, 2025 • By Rica Bhattacharyya

India's pharma and healthcare sector saw 57 deals worth $1.30 billion in Q2, a drop from the previous quarter. Pharma and biotech led in value, driven by capital raises, while hospital platforms saw consolidation and regional expansion. HealthTech and Diagnostics also attracted investor interest, but public market activity was subdued with no IPOs recorded.

July 16, 2025 • By Department for Science, Innovation and Technology

The UK government has launched a new Life Sciences Sector Plan, aiming to harness British science and innovation for long-term economic growth and a stronger NHS. The plan, part of the government's Industrial Strategy, sets out a 10-year mission to deliver new treatments, faster diagnoses, and improved health outcomes. Key actions include: 1. Unlocking NHS data to find new cures with a £600 million investment. 2. Speeding up clinical trials by cutting red tape. 3. Backing British manufacturing with up to £520 million in funding. 4. Simplifying regulation to get new treatments to patients faster. 5. Introducing an NHS 'passport' to roll out proven tools faster. 6. Supporting fast-growing companies to raise investment and scale up. The plan has been shaped with input from over 250 organizations and has received widespread support from industry leaders, academics, and healthcare professionals. The government has committed £2 billion in funding to support the plan, which aims to make the UK a global leader in life sciences, driving economic growth and improving health outcomes.

July 15, 2025 • By Amy Feldman, Forbes Staff, Amy Feldman, Forbes Staff https://www.forbes.com/sites/amyfeldman/

Here is a concise summary of the news article: Daniel Nadler, a 42-year-old Harvard Ph.D., has become a billionaire after founding OpenEvidence, a startup that uses artificial intelligence to help doctors find the best medical information. The company's software searches millions of peer-reviewed publications to provide accurate answers to clinical questions. OpenEvidence has signed up 40% of doctors in the US, with 430,000 users, and is adding 65,000 new users per month. The company has raised $210 million in funding, valuing it at $3.5 billion, and Nadler's net worth is estimated at $2.3 billion. OpenEvidence's AI technology has the potential to revolutionize the way doctors access medical information, and its ad-based business model could generate significant revenue. However, some experts have raised concerns about the accuracy of AI-based search results and the potential for errors in medical literature. Despite these challenges, OpenEvidence's momentum has been impressive, and it is poised to continue growing and improving its technology.

July 14, 2025 • By Research and Markets

The "NLP in Healthcare & Life Sciences Market" report forecasts the market to grow from $5.18 billion in 2025 to $16.01 billion by 2030, driven by a 25.3% CAGR. The surge in unstructured clinical data drives the need for NLP technologies to extract insights. Natural Language Generation (NLG) is expected to be the fastest-growing segment, enhancing documentation and reducing physician workload. Named Entity Recognition (NER) holds the largest market share, crucial for extracting structured information from unstructured medical texts. North America leads the market, while Asia Pacific shows the fastest growth, driven by healthcare digitization and AI investment. The report profiles major players and provides analysis of market dynamics, applications, and regional insights.

July 14, 2025 • By businessinsider.com

Here is a concise summary of the news article: The US market showed mixed results, with the Dow Jones down 300 points and Nasdaq reaching record highs. Tesla's earnings revealed a sharp profit decline, with CEO Elon Musk warning of challenging quarters ahead. Alphabet plans to invest $85 billion in AI by 2025. The European Central Bank held interest rates steady amid economic uncertainty. The US and Japan reached a trade agreement, imposing 15% tariffs on Japanese vehicles. The Trump administration released an AI Action Plan, prioritizing deregulation to accelerate US global AI dominance. Other notable news includes Union Pacific's potential acquisition of Norfolk Southern, sluggish US new home sales, and mixed earnings results from major companies. Geopolitical tensions escalated in various regions, including the border conflict between Thailand and Cambodia and the Israel-Gaza conflict. The US job market remains strong, with declining jobless claims. Retail investors are dominating stock market activity, driving momentum and shaping trades.